About Innovative Medicine
Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine.
Please note that this role is available across multiple countries and may be posted under different requisition numbers to comply with local requirements. While you are welcome to apply to any or all of the postings, we recommend focusing on the specific country(s) that align with your preferred location(s):
United States - Requisition Number: R-030471
Switzerland - Requisition Number: R-032799
Ireland and Belgium - Requisition Number: R-032800
Remember, whether you apply to one or all of these requisition numbers, your applications will be considered as a single submission.
We are searching for the best talent for a Director, Supply Chain Resilience! This hybrid position will be located in Titusville, New Jersey (USA). Alternate hybrid locations may be considered at other Johnson & Johnson Innovation Medicine Supply Chain (IMSC) hubs such as at Horsham, Pennsylvania (USA); Zug, Switzerland; Cork, Ireland; or Beerse, Belgium.
As a member of the Value Chain Management (VCM) organization within the IMSC, the Director Supply Chain Resilience is responsible for providing guidance and recommendation to functional supply chain leaders on end-to-end (E2E) supply chain risk management and resilience through fact-based management tools and strategies. The Director provides strategic oversight to sustain and improve IMSC capability to effectively identify, prioritize, and mitigate strategic risk that may compromise IMSC reliable product supply.
Are you interested in joining a team that is positively impacting patients' lives by collaborating with multi-discipline supply chain teams to assess, illuminate, and mitigate E2E supply chain risk that threaten continuity of patient supply, and to further strengthen E2E supply chain resilience for our Innovative Medicine product portfolio? Apply now for this exciting opportunity!
KEY RESPONSIBILITIES:
Lead and be responsible for the Value Chain Risk Management (VCRM) process for IMSC across the products and entire product portfolio
Lead prioritization of product assessments and refreshes, ensuring progress to plan (for Value Chain Lead (VCL)/Value Chain Teams (VCTs) to implement)
Drive the VCLs to create robust resilience and Business Continuity Plan (BCP) strategies for their products (creation of the mitigation action plan (MAP) from the assessment)
Mature product supply risk processes to improve effectiveness, consistency, portfolio level and with the functions (Manufacturing & Technical Operations (MTO), Deliver, Source, and Plan) on a creating a consolidated view on IMSC risk and resiliency
Mature digital strategy and deliver roadmap of digital capabilities and tools to improve performance, efficiency, and consistency of the critical risk and resilience processes
Provide portfolio-based overview to ensure individual product BCPs/MAPs are aligned to the functional strategies and make sense across the portfolio of products
Lead consolidation of MAPs across products and sites and ensure alignment with customers on prioritization
Consolidate the resilience investment for Long Range Finance Plan / Business Plan (LRFP/BP) for product and portfolio BCPs/MAPs, (includes dual sourcing as well as inventory strategies) and drive and influence portfolio level business trade off decisions
Track progress of product MAPs, with a cadence of updates to VCM and IMSC Leadership, and provide input to the JJSC VCRM team on IMSC progress
Facilitate IMSC level management review on product and portfolio level value chain resiliency
Lead IMSC and cross-functional teams in evaluating and establishing mitigation strategies against enterprise-wide strategic risk to product supply (e.g., geopolitical)
Ensure IMSC, VCM, and VCL awareness and compliance of new and emerging governmental regulations on product supply BCP requirements
Participate in crisis management / recovery activities as required, and potentially play a leading role in the event the crisis is cross-product and IMSC focused
Act as the primary liaison to JJSC VCRM and through this relationship actively participate in shaping, improving, and implementing standards processes, risk policies, and insights creation
Support JJSC in communicating to governments and customers on BCP policy
QUALIFICATIONS:
EDUCATION:
Minimum of a Bachelor’s/University or equivalent degree is required; Master's or MBA degree preferred
EXPERIENCE AND SKILLS:
Required:
Minimum 10 years of relevant work experience
Demonstrated Supply Chain business experience, including a strong knowledge end-to-end (E2E) supply chain (e.g., Value Chain Management, etc.)
Broad experience with proven results in the use and deployment of Continuous Improvement methodologies (e.g., Six Sigma, Lean, or Kepner-Tregoe)
Experience with risk management processes and the demonstrated ability to translate and effectively communicate to senior level stakeholders
Strong consensus management and collaboration skills, and ability to build effective partnering relationships and influence across functions and without direct authority
Preferred:
Experience within Pharmaceutical or related industry
Deep insight and understanding of overall business environment, business insight, outside orientation and networking capability
Strong and methodical process thinker, with the ability to lead all aspects of the linkage between strategy, outcomes, drivers and business processes
Demonstrated global leadership skills/competencies
Strong systems and data leadership skills to drive the use of analytics
OTHER:
Requires proficiency in English (written and verbal) to communicate effectively and professionally
Requires up to 30% domestic and international travel depending on work location and business needs
Requires the ability, through our flexible work policy, to work on-site a minimum of three days each week, with the option for two remote workdays each week
#LI-Hybrid